TuisCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Vorige sluiting
$163,64
Dagwisseling
$159,65 - $163,00
Jaarwisseling
$159,65 - $275,00
Markkapitalisasie
8,30 mjd USD
Gemiddelde volume
802,66 k
P/V-verhouding
20,27
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,01 mjd | -1,64% |
Bedryfskoste | 219,42 m | 5,38% |
Netto inkomste | 69,66 m | -20,29% |
Netto winsgrens | 6,90 | -18,92% |
Wins per aandeel | 2,59 | -4,78% |
EBITDA | 236,55 m | -4,13% |
Effektiewe belastingkoers | 22,96% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 210,17 m | 33,72% |
Totale bates | 8,00 mjd | 5,22% |
Totale aanspreeklikheid | 4,18 mjd | -1,88% |
Totale ekwiteit | 3,83 mjd | — |
Uitstaande aandele | 51,14 m | — |
Prys om te bespreek | 2,21 | — |
Opbrengs op bates | 4,65% | — |
Opbrengs op kapitaal | 5,62% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 69,66 m | -20,29% |
Kontant van bedrywe | 251,79 m | 22,56% |
Kontant van beleggings | -21,32 m | 73,20% |
Kontant van finansiering | -207,54 m | -27,43% |
Netto kontantverandering | 30,64 m | 170,98% |
Beskikbare kontantvloei | 223,49 m | 120,91% |
Meer oor
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Gestig
1947
Webwerf
Werknemers
21 100